Product Images Tizanidine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Tizanidine NDC 68084-775 by American Health Packaging, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medication called Tizanidine, available in the form of a Tablet with a strength of 2mg. The text also contains some unreadable characters and cannot be used further.*
This is a description of Tizanidine tablets with NDC number 68084-775-25. It is a prescription drug used for muscle spasms. The tablets contain 2.288 mg tizanidine hydrochloride USP, equivalent to 162 mg lizanidine base. It is important to note that the tablets are not interchangeable with Tizanidine capsules. The recommended dosage can be found in the package insert. The tablets should be stored between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The drug product is distributed by American Health Packa in Columbus, Ohio.*
This is a partial description of a medication named Tizanidine. The text includes some information such as dosage ("4mg") and possibly side effects or warnings (unclear due to poor quality). However, some sections of the text are not legible so a complete description cannot be generated.*
The text is describing a drug called Tizanidine in tablet form. The pills come in a pack of 100 tablets, with 10 per strip. The tablets contain 4 mg of Tizanidine hydrochloride USP, and each package includes full prescribing information. The text also warns that the tablets are not interchangeable with Tizanidine capsules, and recommends storing the tablets at room temperature. The product is manufactured by Dr. Reddy's Laboratories Limited and distributed by American Health Packaging in Columbus, Ohio.*
The text describes the improvement in Ashworth Score for a medication called Zanidine. The mean dose used in the study was 28.6 mg. The timeframe of the study was from week 3 to the end of maintenance endpoint, which was during study week 7. The method of observation was forward-garred.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.